...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Month 10
2
Apr 14, 2017 08:49PM

All this quiet time with Zenith is making me think that something very significant is being negotiated and that possibly a deal is in the works , Not sure how fair it would be to a possible acquiring company for Zenith to announce good results in phase 1 when you finalizing a deal,  being a private company Zentih has more leeway in when and how they announce any news 

 

 

3
Apr 16, 2017 03:49PM
4
Apr 16, 2017 05:19PM
3
Apr 16, 2017 07:16PM
2
Apr 16, 2017 08:15PM

Apr 18, 2017 10:55AM
3
Apr 18, 2017 12:08PM
2
Apr 18, 2017 12:49PM
Share
New Message
Please login to post a reply